MedTrace Logo

Evaluation of Cross-Linked Polyelectrolyte (CLP) in Healthy Volunteers

NCT01944007 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2013-09-17

No results posted yet for this study

Summary

This is a dose-escalation study to determine the effect of CLP in normal healthy volunteers.

Conditions

  • Basic Science: Safety, Tolerability, Efficacy of CLP

Interventions

DRUG

Cross-Linked Polyelectrolyte (CLP)

CLP was administered orally, in capsules, for 9 consecutive days.

Sponsors & Collaborators

  • Sorbent Therapeutics

    lead INDUSTRY

Principal Investigators

  • Thomas Blok, MD · Jasper Clinic, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2008-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01944007 on ClinicalTrials.gov